CapWealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

CapWealth Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-9,615	Closed	-$544K	–	101
2024 Q4	$544K	Hold	9,615	–	–	0.06%	71
2024 Q3	$497K	Hold	9,615	–	–	0.05%	72
2024 Q2	$399K	Hold	9,615	–	–	0.05%	69
2024 Q1	$521K	Sell	9,615 -2,148	-18%	-$109K	0.06%	65
2023 Q4	$604K	Hold	11,763	–	–	0.07%	63
2023 Q3	$683K	Sell	11,763 -1,000	-8%	-$61.3K	0.09%	69
2023 Q2	$816K	Hold	12,763	–	–	0.1%	66
2023 Q1	$885K	Hold	12,763	–	–	0.11%	66
2022 Q4	$918K	Hold	12,763	–	–	0.11%	69
2022 Q3	$907K	Hold	12,763	–	–	0.12%	66
2022 Q2	$983K	Hold	12,763	–	–	0.12%	69
2022 Q1	$932K	Hold	12,763	–	–	0.1%	81
2021 Q4	$796K	Buy	12,763 +3,148	+33%	+$185K	0.08%	83
2021 Q3	$569K	Hold	9,615	–	–	0.06%	85
2021 Q2	$642K	Hold	9,615	–	–	0.07%	80
2021 Q1	$607K	Sell	9,615 -191	-2%	-$11.9K	0.07%	79
2020 Q4	$608K	Buy	9,806 +41	+0.4%	+$2.52K	0.07%	75
2020 Q3	$589K	Sell	9,765 -250	-2%	-$15K	0.08%	72
2020 Q2	$589K	Sell	10,015 -460	-4%	-$27.5K	0.08%	71
2020 Q1	$584K	Sell	10,475 -163,667	-94%	-$10M	0.1%	63
2019 Q4	$11.2M	Sell	174,142 -2,707	-2%	-$155K	1.41%	27
2019 Q3	$8.97M	Sell	176,849 -27,925	-14%	-$1.31M	1.19%	30
2019 Q2	$9.29M	Sell	204,774 -2,873	-1%	-$134K	1.33%	29
2019 Q1	$9.91M	Buy	207,647 +2,457	+1%	+$122K	1.52%	24
2018 Q4	$10.7M	Buy	205,190 +17,592	+9%	+$945K	1.87%	21
2018 Q3	$11.6M	Buy	187,598 +1,960	+1%	+$116K	1.91%	16
2018 Q2	$10.3M	Buy	185,638 +4,241	+2%	+$229K	1.84%	18
2018 Q1	$11.5M	Sell	181,397 -10,518	-5%	-$677K	2.22%	17
2017 Q4	$11.8M	Buy	191,915 +2,966	+2%	+$186K	2.12%	17
2017 Q3	$12M	Buy	188,949 +2,332	+1%	+$136K	2.31%	16
2017 Q2	$10.4M	Sell	186,617 -265	-0.1%	-$14.4K	2.08%	19
2017 Q1	$10.2M	Sell	186,882 -1,825	-1%	-$100K	2.08%	18
2016 Q4	$11M	Buy	188,707 +26,173	+16%	+$1.43M	2.39%	14
2016 Q3	$8.76M	Sell	162,534 -5,153	-3%	-$331K	2.11%	18
2016 Q2	$12.3M	Sell	167,687 -1,450	-0.9%	-$102K	3.01%	7
2016 Q1	$10.8M	Sell	169,137 -6,605	-4%	-$417K	2.75%	11
2015 Q4	$12.1M	Sell	175,742 -2,776	-2%	-$183K	2.93%	9
2015 Q3	$10.6M	Sell	178,518 -6,170	-3%	-$391K	2.65%	11
2015 Q2	$12.3M	Buy	184,688 +4,527	+3%	+$298K	2.9%	10
2015 Q1	$11.6M	Buy	180,161 +400	+0.2%	+$25K	2.73%	10
2014 Q4	$10.6M	Sell	179,761 -175	-0.1%	-$9.87K	2.49%	10
2014 Q3	$9.21M	Buy	179,936 +1,885	+1%	+$94.2K	2.09%	15
2014 Q2	$8.64M	Buy	178,051 +2,580	+1%	+$127K	1.98%	15
2014 Q1	$9.12M	Buy	175,471 +125	+0.1%	+$6.65K	2.45%	14
2013 Q4	$9.32M	Sell	175,346 -15,209	-8%	-$775K	2.35%	14
2013 Q3	$8.82M	Buy	190,555 +1,970	+1%	+$86.5K	2.45%	14
2013 Q2	$8.43M	Buy	+188,585	New	+$8.19M	2.46%	13

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CapWealth Advisors's BMY Position: Q1 2025 in Review

CapWealth Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 9,615 shares — an estimated $544K sold.

CapWealth Advisors first reported a position in BMY in Q2 2013 and held it in 47 quarters. The position peaked at $12.3M in Q2 2016. 2,478 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

CapWealth Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
CapWealth Advisors sold 9,615 Bristol-Myers Squibb shares in Q1 2025, an estimated $544K.
CapWealth Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 47 quarters.
CapWealth Advisors's Bristol-Myers Squibb position peaked at $12.3M in Q2 2016.
2,478 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on CapWealth Advisors's 13F filing for Q1 2025, filed 30 Apr 2025.